Search Results

There are a lot of important things to think about before deciding to participate in a trial.

https://www.csl.com/research-and-development/clinical-studies/how-to-participate

Answers to the most frequently asked questions about Clinical Trials.

https://www.csl.com/research-and-development/clinical-studies/clinical-studies-faqs

Clinical Trials Day Is May 20. Follow the journey of a potential treatment through four important phases.

https://www.csl.com/we-are-csl/vita-original-stories/2023/infographic-what-is-a-clinical-trial

CSL conducts clinical trials on all of its products. See if one of our current clinical trials might be right for you.

https://www.csl.com/research-and-development/clinical-studies/current-clinical-trials

CSL's clinical trials are one of the most important steps in the years-long process of obtaining approval for new medications.

https://www.csl.com/research-and-development/clinical-studies

CSL conducts clinical trials in accordance with our Code of Responsible Business Practice and the current Guideline for Good Clinical Practice (GCP) of the International Conference on Harmonization (ICH).

https://www.csl.com/research-and-development/clinical-studies/research-practices

Clinical trial participants should mirror the population, but minorities are underrepresented.

https://www.csl.com/we-are-csl/vita-original-stories/2023/video-why-diversity-matters-in-clinical-trials

CSL is among the founding members of PALADIN, a new organization formed to optimize the way industry works with patient advocacy groups in researching new treatments.

https://www.csl.com/we-are-csl/vita-original-stories/2023/a-consortium-to-improve-clinical-trials

Osaka, JAPAN and King of Prussia, Pa., USA - October 8, 2020 - The CoVIg-19 Plasma Alliance, an unprecedented collaboration of leading plasma companies supported by global organizations outside the plasma industry, today confirmed that patients are now being enrolled in the Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) Phase 3 clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

https://newsroom.csl.com/2020-10-08-First-Patient-Enrolled-in-NIH-Phase-3-Trial-to-Evaluate-Potential-COVID-19-Hyperimmune-Medicine

Sparsentan was well-tolerated with a consistent safety profile across all clinical trials conducted to date and comparable to irbesartan

https://newsroom.csl.com/2023-05-02-Topline-Results-from-Two-Year-Primary-Efficacy-Endpoint-in-Pivotal-Phase-3-DUPLEX-Study-of-Sparsentan-in-Focal-Segmental-Glomerulosclerosis